Results 271 to 280 of about 2,904,132 (380)

Classifying knowledge used in complementary medicine consultations: a qualitative systematic review. [PDF]

BMC Complement Med Ther, 2022
Davies K, Heinsch M, Tickner C, Brosnan C, Steel A, Patel G, Marsh M.   +6 more
europepmc   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Digital radiography image quality evaluation using various phantoms and software

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose To investigate the effect of the exposure parameters on image quality (IQ) metrics of phantom images, obtained automatically using software or from visual evaluation. Methods Three commercial phantoms and a homemade phantom constructed according to the instructions given in the IAEA Human Health Series No.
Ioannis A. Tsalafoutas, Shady AlKhazzam, Virginia Tsapaki, Huda AlNaemi, Mohammed Hassan Kharita   +4 more
wiley   +1 more source

Fostering the Conversation About Complementary Medicine: Acceptability and Usefulness of Two Communication-Supporting Tools for Patients with Cancer. [PDF]

Curr Oncol
Mentink M, Noordman J, Timmer-Bonte A, Busch M, van Dulmen S.   +4 more
europepmc   +1 more source

Complementary Medicine Practice and Use of Dietary Supplements in Pediatric Cancer Patients in Croatia. [PDF]

Cureus, 2022
Kranjcec I, Abdovic S, Buljan D, Matijasic N, Slukan M, Stepan J.   +5 more
europepmc   +1 more source

Complementary medicine use by Mexican migrants in the San Francisco Bay Area [PDF]

, 2001
Valentina Napolitano
openalex   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

Effect of alternative and complementary medicine on male infertility: An umbrella review. [PDF]

Health Sci Rep
Fasanghari M, Keramat A, Tansaz M, Moini A, Chaman R.   +4 more
europepmc   +1 more source

West Virginians' perceptions and use of complementary medicine

, 2000
Joshua David Blevins
openalex   +2 more sources

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source